Aemetis (NASDAQ:AMTX) Shares Cross Below 200 Day Moving Average - Time to Sell?

Key Points

• Aemetis shares fell below their 200-day moving average, trading near $1.88 versus the $2.13 average, signaling technical weakness.
• Analyst sentiment is mixed: Ascendiant Capital maintained a Buy rating with a $22 price target, while Weiss Ratings issued a Sell rating and Wall Street Zen upgraded the stock to Hold. The consensus rating is Hold, with an average target of $11.88.
• Aemetis beat quarterly EPS expectations with a loss of $0.13 per share versus the projected $0.29 loss, but revenue of $62.7 million fell short of estimates. Institutional investors own approximately 27% of the company.

Shares of Aemetis, Inc (NASDAQ:AMTX - Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.13 and traded as low as $1.8750. Aemetis shares last traded at $1.88, with a volume of 475,755 shares trading hands.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on AMTX. Ascendiant Capital Markets upped their price objective on Aemetis from $21.00 to $22.00 and gave the stock a "buy" rating in a research note on Friday, May 22nd. Weiss Ratings restated a "sell (e+)" rating on shares of Aemetis in a research report on Friday, July 17th. Finally, Wall Street Zen raised Aemetis from a "sell" rating to a "hold" rating in a report on Saturday, August 22nd. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $11.88.

Aemetis Trading Down 1.1%

The firm's 50-day moving average price is $1.75 and its 200-day moving average price is $2.13. The stock has a market capitalization of $135.68 million, a PE ratio of -2.07 and a beta of 1.47.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.29) by $0.16. The company had revenue of $62.70 million for the quarter, compared to analysts' expectations of $67.69 million. On average, equities research analysts predict that Aemetis, Inc will post -0.89 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of AMTX. Bank of New York Mellon Corp bought a new stake in shares of Aemetis in the 2nd quarter worth about $283,000. Bank of America Corp DE raised its position in Aemetis by 148.3% in the 1st quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company's stock worth $324,000 after purchasing an additional 60,611 shares during the period. Royal Bank of Canada lifted its stake in Aemetis by 10,632.5% in the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company's stock worth $28,000 after purchasing an additional 8,825 shares during the last quarter. Renaissance Technologies LLC bought a new stake in Aemetis in the first quarter worth about $272,000. Finally, Sanctuary Advisors LLC purchased a new position in shares of Aemetis during the first quarter valued at approximately $33,000. Institutional investors own 27.02% of the company's stock.

About Aemetis

Aemetis, Inc is a renewable fuels and biochemicals company focused on developing and operating technologies that reduce greenhouse gas emissions. Its activities include the production of renewable natural gas, renewable fuels, and other low-carbon products derived from agricultural and organic waste.

The company's Aemetis Biogas business develops and operates dairy-waste digesters and related infrastructure in California's Central Valley. These systems capture methane from dairy manure and convert it into renewable natural gas for transportation and other energy applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.